Lumbosacral necrotizing fasciitis after thoracic drainage: a case report documenting subcutaneous and fascial spread Authors: Wei Li, Hui Shen, Qing Li, Jie Wu, Mingfeng Han, Quankui Zhuang Published: 2026 ABSTRACT AbstractNecrotizing fasciitis (NF) rarely spreads from the chest to the lumbosacral region. We report a fatal case in a 61-year-old man, documented by serial imaging and surgical exploration, that provides strong evidence suggesting subcutaneous and fascial spread of infection from a thoracic drainage site. This case highlights a rare but deadly complication and suggests that increased vigilance may be warranted in immunocompromised patients. Keywords: Case report, Chest tube, Complication, Empyema, Necrotizing fasciitis, Subcutaneous emphysema Introduction Necrotizing fasciitis is a life-threatening, rapidly progressive infection of the deep soft tissues, with a high mortality rate despite aggressive treatment. While typically arising from localized trauma or surgical sites, hematogenous or contiguous spread from a distant focus can occur [1]. The dissemination of infection from the thoracic cavity along anatomical fascial planes to the lumbosacral region represents an exceptionally rare and clinically ominous route [2, 3]. Such progression is poorly documented in the literature, often leading to delayed diagnosis [4]. Here, we present a fatal case of lumbosacral NF that originated from an empyema following closed thoracic drainage. This case is uniquely instructive as it provides a complete chain of evidence—through serial radiological imaging, surgical exploration, and concordant microbiology—that vividly delineates the subcutaneous and fascial “highway” traversed by the infection. Case presentation A 61-year-old man with a history of alcoholic cirrhosis, chronic heavy smoking (approximately 30 cigarettes/day), and significant daily alcohol intake (about 500 g of liquor daily) was transferred to our hospital after a protracted and complicated clinical course. Six days before the procedure, he developed chest tightness, cough, and expectoration at an external clinic. An initial chest computer tomography (CT) suggested left-sided pneumonia, pleurisy, and pleural effusion (images unavailable), leading to referral to a secondary hospital. On day 0, he was hospitalized with a diagnosis of left-sided pneumonia with pleural effusion. Emergency ultrasound-guided closed thoracic drainage was performed using a chest tube inserted at the posterior axillary line (tube size not specified), yielding approximately 500 mL of foul‑smelling, yellowish purulent fluid. Samples of pleural fluid and sputum were sent for microbiological culture. Daily drainage volumes over the following days were as follows (mL): 1000, 550, 600, 300, 100, 70, 50, 0, and 0. The chest tube was removed on day 9. Empirical antibiotic therapy with intravenous cefuroxime (1.5 g every 12 h) was started, along with supportive measures including expectorants and albumin supplementation. On day 3, the patient reported severe pain in the lumbosacral region, though the overlying skin appeared normal without erythema, swelling, or warmth. This symptom was managed with injectable lornoxicam without further investigation. On day 7, the area had become erythematous, swollen, warm, and tender, accompanied by persistent high fever (38.4 ℃) requiring antipyretics plus dexamethasone. Initial pleural fluid and sputum cultures were negative; however, a repeat culture of drainage fluid from on day 9 subsequently grew Staphylococcus aureus. Based on antimicrobial susceptibility testing, therapy was switched to intravenous moxifloxacin (400 mg once daily). Despite this change, his clinical status continued to decline. The skin over the lower back progressively darkened and became necrotic, with foul‑smelling exudate. Systemic deterioration ensued, including altered mental status and hemodynamic instability. On day 13, the antimicrobial regimen was escalated to vancomycin combined with piperacillin‑tazobactam. Key events are summarized in Table 1. Table 1Timeline of key clinical eventsTime PointEventDay 0Closed thoracic drainage for empyemaDay 3Severe lumbosacral pain; CT shows subcutaneous emphysema to perirenal leveDay 7Lumbosacral erythema, swelling, feverDay 13Repeat CT: emphysema extends to lumbosacral regionDay 14Transfer to our hospital; surgical debridement; intraoperative tract confirmedDay 18Death from multi‑organ failure Timeline of key clinical events Physical examination On admission (day 14), the patient was lethargic but arousable, with pallor and a Glasgow Coma Scale score of 14.Vital signs were as follows: temperature 38.4℃, pulse 101 beats/min, respiratory rate 22 breaths/min, blood pressure 101/64 mmHg. Neck examination revealed no abnormalities. Chest examination showed reduced movement of the left chest wall. A 1.5 cm unhealed incision from the prior chest tube removal was present on the left posterior chest wall, surrounded by erythema and edema. Subtle crepitus was palpable inferior to the incision. Tactile fremitus was increased over the left lower lung field; percussion was dull at the lung bases and tympanitic superiorly. Breath sounds were diminished, with audible crackles. Cardiac and abdominal examinations were unremarkable. Examination of the back revealed an area of 25 cm×15 cm of blackened necrotic skin over the lumbosacral region, with marked tenderness and fluctuance. Pressure elicited foul-smelling exudate and mild crepitus. Neurological examination of all four limbs was normal, with intact sensation and motor function. Summary of laboratory findings at admission and during prior course The serial laboratory results are detailed in Table 2. The Laboratory Risk Indicator for Necrotizing Fasciitis Score (LRINEC) [5] on admission was 6 (based on C-reactive protein 233 mg/L, white-cell count 6.35 × 10⁹/L, hemoglobin 96 g/L, serum sodium 136.6 mmol/L, blood glucose 6.01mmol/L, and creatinine 46 µmol/L), indicating a moderate to high risk of necrotizing fasciitis. Acute Physiology and Chronic Health Evaluation II (APACHE II) [6]score was calculated using available admission data (age, vital signs, laboratory values including hematocrit 27.7%, Glasgow Coma Scale, and chronic health points for cirrhosis). Arterial blood gas was not obtained, but the patient was breathing room air with SpO2 94%, allowing estimation of normal oxygenation. Under these assumptions, the APACHE II score was 13, corresponding to a predicted mortality of approximately 15–20%. Table 2Laboratory findings at admission and during prior courseParameterDay 1Day 9Day 13a Day 14 White-cell count (×10⁹/L) 13.256.518.426.35 Neutrophils (%)89.889.692.690.6 Lymphocytes (%)4.76.14.86.3 Monocytes (%)4.93.71.72 Eosinophils (%)0.100.11.1 Basophils (%)0.50.040.80 Platelets (×10⁹/L) 244245144108 Hemoglobin (g/L) 14011311296 C-reactive protein(mg/L) 212.4--233 Erythrocyte sedimentation rate (mm/hr) ---28 Total Protein (g/L) 51.443.140.743.8 Albumin (g/L) 22.419.517.120.7 Alanine aminotransferase (U/L) 5.6705947 Aspartate aminotransferase (U/L) 207424648 Na + (mmol/L) 136137137136.6 Serum creatinine(umol/L) 50444346 Blood Glucose(mmol/L) 6.56.744.986.01 Blood Cultures bNegativeNote: The dash (—) indicates that the test was not performed or the result was not available for that time point.a: Post-drainage Day 14 corresponds to the day of admission to our hospital.b༚Multiple blood cultures were obtained during this period, all of which showed no growth Laboratory findings at admission and during prior course Note: The dash (—) indicates that the test was not performed or the result was not available for that time point.a: Post-drainage Day 14 corresponds to the day of admission to our hospital.b༚Multiple blood cultures were obtained during this period, all of which showed no growth Imaging studies CT Scan (Post‑drainage day 3): Non‑contrast CT of the chest and upper abdomen (5 mm contiguous slices, viewed in soft-tissue and lung windows) demonstrated an irregular, high‑density shadow (approx. 2.8 cm × 2.2 cm) with ragged margins adjacent to the left major fissure, associated with pleural thickening. Multiple patchy ground‑glass opacities and consolidation were present in the left lower lobe. Bilateral pleural effusions, left‑sided dominant, were seen along with a small pneumothorax. The left chest drainage tube remained in situ. Extensive subcutaneous emphysema was noted tracking along the tube tract and into the surrounding soft tissues, accompanied by blurred subcutaneous fat stranding and hazy, flocculent soft‑tissue densities consistent with exudate or edema. These abnormalities extended inferiorly along the chest wall to the level of the ipsilateral kidney (Fig. 1). CT Scan of the Chest and Upper Abdomen without Contrast on Post-drainage Day 3. Panel A shows a left-sided pleural effusion with pneumothorax. Panel B demonstrates consolidation in the left lower lobe. Panel C shows the closed thoracic drainage tube in situ, with gas densities visible in the surrounding soft tissues. Panel D reveals extensive subcutaneous and intermuscular emphysema within the left chest wall. Panels E and F (serial scans from cranial to caudal) show the subcutaneous emphysema tracking inferiorly along the paraspinal compartment. Panels G and H show the emphysema extending to the level of the bilateral perirenal spaces CT Scan (Post‑drainage day 13): Follow‑up non‑contrast CT of the chest and whole abdomen showed mild reduction in left lower lobe consolidation. Bilateral pleural effusions had increased, and a large air‑fluid level was now visible within the left pleural cavity. Although subcutaneous emphysema in the upper back had diminished, it now exhibited extensive inferior extension into the lumbosacral region (Fig. 2). CT Scan of the Chest and Whole Abdomen without Contrast on Post-drainage Day 13. Panel A shows that the consolidation in the left lower lobe has decreased in size compared to previous imaging. Panel B shows the subcutaneous emphysema has extended into the paraspinal region of the upper back. Panel C shows a reduction in the extent of subcutaneous emphysema in the chest wall compared to prior. Panel D demonstrates the presence of emphysema within the bilateral paraspinal compartments. Panel E shows paraspinal emphysema at the level of the renal pelvis. Panels F, G, and H show that the subcutaneous emphysema has now disseminated to the lumbosacrococcygeal region Magnetic Resonance Imaging (MRI) Scan (Post‑drainage day 14):A sagittal MRI of the lumbar spine (field of view L1-S1) was also obtained, but the scans incidentally included the lower thoracic region. On T2-weighted images, there was subtle hyperintensity within the subcutaneous tissue at the level of T11-T12, suggestive of inflammatory edema. Corresponding T1-weighted images showed mildly increased signal in the same area, which may represent either hemorrhagic exudate or fat interlacing within the inflamed tissue. No definite fascial defect or continuous tract from the chest tube site was visible, partly due to the limited field of view. These findings, while not diagnostic of the complete fascial pathway, are consistent with early soft‑tissue inflammation in the region (Fig. 3). Sagittal MRI of the thoracolumbar spine (field of view L1–S1, incidentally including T11–T12). (A–C) T2‑weighted images show subtle hyperintensity within the subcutaneous tissue at the T11–T12 level, suggestive of inflammatory edema. (D–F) Corresponding T1‑weighted images demonstrate mildly increased signal in the same area, possibly representing hemorrhagic exudate or fat interlacing. No definitive fascial defect or continuous tract from the chest tube site was visible, partly due to the limited field of view Diagnosis Sepsis secondary to extensive lumbosacral necrotizing fasciitis and pyopneumothorax, originating from infection at the thoracic drainage site. Treatment Following admission, the patient underwent emergency surgical intervention under general anaesthesia. The procedure included radical debridement of the necrotic tissue in the lumbosacral region (Fig. 4), application of continuous vacuum-assisted closure (VSD), and debridement with primary suture closure of the thoracic drainage site. Intraoperative exploration confirmed a necrotic subcutaneous tract connecting the chest tube insertion site to the lumbosacral area, with extensive tissue necrosis noted along the pathway. Tissue samples from both sites were collected for microbiological culture. Perioperative blood transfusion was administered to correct anaemia. Gross appearance and intraoperative findings. Panel A shows a large area of blackened, necrotic skin on the lumbosacral region, with the unhealed incision from the closed thoracic drainage tube visible. Panel B, taken during debridement surgery, reveals extensive necrosis of the deep fascia in the lumbosacral region Postoperatively, the intravenous anti-infective regimen of vancomycin plus piperacillin-tazobactam was maintained, supplemented by local continuous irrigation with gentamicin solution. Outcome Tissue cultures from both the lumbosacral site and the chest tube site were collected intraoperatively under sterile conditions, transferred immediately to the laboratory, and processed within 30 min.Standard aerobic culture was performed on blood agar, MacConkey agar, and chocolate agar incubated at 37℃ for 48 h. No anaerobic cultures were performed. Escherichia coli and Staphylococcus haemolyticus grew from both specimens. Antimicrobial susceptibility testing (AST) was performed using the VITEK 2 system (bioMérieux). The Escherichia coli isolate was susceptible to piperacillin-tazobactam (MIC ≤ 4/4 µg/mL), meropenem (≤ 0.25 µg/mL), and ciprofloxacin (≤ 0.5 µg/mL), but resistant to cefuroxime (≥ 32 µg/mL). The Staphylococcus haemolyticus isolate was susceptible to vancomycin (≤ 1 µg/mL) and linezolid (≤ 1 µg/mL) but showed intermediate resistance to cefuroxime (8 µg/mL). Histopathologic examination of debrided fascial tissue showed extensive coagulative necrosis of the deep fascia with loss of normal fibrillar architecture. A diffuse inflammatory infiltrate was present throughout the necrotic areas. Precise identification of cell types was limited by the low magnification used. The patient’s clinical condition continued to deteriorate critically. Notable laboratory findings at this stage included: white-cell count 7.95 × 10⁹/L (neutrophils 93.8%), platelets 20 × 10⁹/L, hemoglobin 109 g/L; C-reactive protein 259.8 mg/L, erythrocyte sedimentation rate 15 mm/h; total protein 47 g/L, albumin 24.5 g/L, alanine aminotransferase 39U/L, aspartate aminotransferase 28U/L. In view of the critical illness and grave prognosis, the family elected to withdraw active treatment after thorough discussion. The patient was discharged at the family’s request and died the following day. Discussion Closed thoracic drainage is a routine procedure for the diagnosis and management of pleural effusion and is associated with a low complication rate. Reported complications include pneumothorax [7], hypoxemia [8], hemothorax from intercostal vessel injury [9], re-expansion pulmonary edema [10], aortic perforation [11], and subcutaneous emphysema of the chest and abdominal wall [12]. However, vigilance for life-threatening complications is warranted in high-risk populations, such as the elderly, immunocompromised individuals, or those with multiple comorbidities. This case presents a rare and lethal progression from a routine thoracic drainage to fatal necrotizing fasciitis of the lumbosacral region, illustrating a previously underappreciated pathway of subcutaneous and fascial dissemination. The patient, a 61-year-old man with alcoholic cirrhosis, represented a highly vulnerable host. His long-term heavy smoking and alcohol use are established risk factors for severe community-acquired pneumonia and poor outcomes, as they compromise respiratory defence mechanisms, alter oropharyngeal flora, and induce systemic immunosuppression [13–15]. This confluence of risk factors set in motion a chain of events that reveals critical gaps in our understanding of fascial spread and the management of complex infections in compromised hosts. Anatomical dissection of infection spread—as illustrated in Fig. 5. Schematic illustration of the proposed fascial spread pathway from the chest tube site to the lumbosacral region. The diagram depicts the hypothesized route of infection: starting from the chest tube site (left posterior chest wall), extending inferiorly through the thoracolumbar fascia and the paraspinal fascia, and ultimately reaching the lumbosacral region. Arrows indicate the direction of contiguous spread along pre-existing anatomical fascial planes, without perforation of the diaphragm. This pathway explains the progressive caudal extension of subcutaneous emphysema and necrotizing fasciitis observed in the patient The serial imaging and microbiological findings in this case vividly illustrate a rare yet anatomically explicable route of fatal infection spread. A non-contrast chest CT on post-drainage day 3 revealed extensive subcutaneous emphysema along the chest tube tract and surrounding soft tissues, indicating a gas-forming bacterial infection that had breached the pleural and chest wall barriers to involve the subcutaneous and fascial planes. Follow-up CT on day 13 demonstrated progression of these changes, with subcutaneous emphysema and inflammatory exudate now extensively involving the lumbosacral region. Crucially, intraoperative exploration revealed a necrotic tract connecting the thoracic drainage site and the lumbosacral area, and tissue cultures from both sites grew identical pathogens (Escherichia coli and Staphylococcus haemolyticus), confirming the thoracic site as the source of the disseminated infection. This pattern of distant spread is best understood within the anatomy of deep fascial planes. The retroperitoneum is not a true cavity but a series of interconnected potential spaces bounded by fascia, which can act as conduits for fluid and infection [16]. Classical anatomical studies have detailed how the psoas compartment communicates with the perirenal and pararenal spaces, creating a continuous pathway from the upper abdomen to the pelvis and thigh [17]. In our patient, we propose that pathogens introduced via the chest tube exploited these pre-existing planes. The initial subcutaneous emphysema along the chest wall (Fig. 1) likely tracked inferomedially into the retroperitoneal interfascial planes. This mechanism is characteristic of retroperitoneal fasciitis, where CT findings of fascial thickening, stranding, and gas tracking—coupled with pain disproportionate to physical signs—are key diagnostic clues [16]. The potential for Necrotizing fasciitis to spread extensively along fascial compartments from distant sites is further supported by other case reports [18]. While CT is the first-line modality for suspected gas-forming infections, MRI offers superior soft-tissue contrast and can detect early fascial edema before subcutaneous emphysema becomes visible [19]. In this case, a lumbar MRI (field of view L1-S1) was performed and incidentally included the lower thoracic region. T2-weighted images showed subtle hyperintensity within the subcutaneous tissue at T11-T12, suggestive of inflammatory edema, while T1-weighted images showed mildly increased signal, possibly representing hemorrhagic exudate or fat interlacing. However, due to the limited field of view, the complete fascial tract from the chest tube site to the lumbosacral region could not be visualized. In retrospect, an MRI covering the entire thoracolumbar spine (from thoracic inlet to sacrum) might have enabled earlier diagnosis of fascial spread. When clinical suspicion persists despite negative or equivocal CT findings, MRI with a broad field of view should be considered as a complementary tool. Therefore, the radiographic evolution in our patient—from localized chest wall emphysema to extensive lumbosacral NF—represents a dramatic demonstration of infection propagating along the thoracolumbar and retroperitoneal fascial continuum. This case provides rare but compelling clinicopathological evidence that a routine thoracic procedure can, in a vulnerable host, initiate an infection that tracks along deep anatomical planes to cause fatal NF at a distant site. We acknowledge, however, that the subcutaneous emphysema observed on CT could have multiple origins: procedural air introduction during chest tube placement is common and may contribute to early findings. Yet the progressive caudal extension over 10 days, the worsening clinical course, and the isolation of a gas-forming organism (Escherichia coli) support an infectious component as the driver of spreading emphysema. Why the defence failed? The fatal trajectory in this case resulted not from a single error, but from the sequential failure of multiple defensive layers in a highly vulnerable host. First, after initial presentation, the patient delayed seeking definitive care for five days despite referral advice, allowing the primary pulmonary infection to progress. Upon admission, empirical antibiotic therapy with a second-generation cephalosporin (cefuroxime) was selected. This choice proved critically inadequate: the foul-smelling, purulent pleural fluid strongly suggested anaerobic involvement, which cefuroxime poorly covers. An appropriate empirical regimen for a post-procedural, foul-smelling empyema in an immunocompromised host should have included anaerobic coverage (e.g., with metronidazole) or utilized a broader-spectrum agent such as piperacillin-tazobactam or a carbapenem [20]. Furthermore, while Staphylococcus aureus is not a leading cause of community-acquired pneumonia [21], its presence in a purulent empyema—later confirmed by culture—renders cefuroxime suboptimal due to its variable activity against β-lactamase-producing strains and complete lack of efficacy against methicillin-resistant Staphylococcus aureus (MRSA). The subsequent switch to moxifloxacin, guided by susceptibility testing, still failed to address the likely anaerobic component. By the time lumbosacral pain emerged—a sign suggesting sepsis with distant soft-tissue involvement—the infection was likely a deep, necrotizing, polymicrobial process for which moxifloxacin monotherapy was insufficient. Even with a susceptible result, the severity of the clinical picture and the healthcare-associated context should have raised immediate suspicion for MRSA. Consequently, empirical therapy did not cover MRSA until the patient was in extremis, when vancomycin was finally added. The ultimate combination of vancomycin and piperacillin-tazobactam was a rational, broad-spectrum regimen for severe complicated infection, including necrotizing fasciitis. However, its initiation occurred only after the patient had developed signs of septic shock and extensive lumbosacral skin necrosis, representing a devastating therapeutic delay. Beyond antibiotic failures, a crucial system-level delay compounded the outcome. The first CT scan (post-drainage day 3) already showed perirenal emphysema, yet this finding was not recognized as a warning sign of deep fascial spread. The patient remained at the outside hospital for another 10 days without surgical consultation or transfer to a higher-level facility. The outside hospital lacked on-site infectious disease and surgical specialists, and transfer occurred only after the patient developed overt septic shock on day 13. In retrospect, earlier transfer (e.g., by day 7) could have enabled timely surgical debridement before extensive tissue necrosis occurred. This 10-day therapeutic window was lost due to a combination of diagnostic oversight and logistical constraints, representing a critical missed opportunity. This series of decisions—initial under-treatment, missed anaerobic and MRSA coverage, late antibiotic escalation, and a 10-day delay in recognising CT findings and arranging transfer—collectively dismantled the pharmacological and surgical defences, permitting uncontrolled infection to disseminate along anatomical planes. Critical crossroad of diagnostic and therapeutic decisions This case presents several pivotal junctures where alternative diagnostic considerations or therapeutic interventions might have altered the fatal course. The following timeline reconstructs the key decision points against the evolving clinical backdrop. A critical analysis of these junctures, particularly regarding antimicrobial strategy, reveals how opportunities for early intervention were missed. Antibiotic decision retrospective: a cascade of under-treatment The antimicrobial strategy exemplifies a reactive rather than proactive approach, failing to match the escalating severity and complexity of the infection. Initial Empirical Choice (Cefuroxime): This was a fundamental misalignment with the clinical scenario. The presentation was not typical community-acquired pneumonia but a post-procedural, healthcare-associated empyema with foul-smelling pus in a cirrhotic patient. Guidelines for complicated parapneumonic effusions/empyema mandate coverage for anaerobes and resistant organisms [22], which cefuroxime does not provide. Initial Empirical Choice (Cefuroxime): This was a fundamental misalignment with the clinical scenario. The presentation was not typical community-acquired pneumonia but a post-procedural, healthcare-associated empyema with foul-smelling pus in a cirrhotic patient. Guidelines for complicated parapneumonic effusions/empyema mandate coverage for anaerobes and resistant organisms [22], which cefuroxime does not provide. The Pivotal Missed Signals: The foul odor of the pleural fluid was a direct microbiological clue ignored. The subsequent development of severe, disproportionate back pain was the cardinal clinical signal of deep fascial invasion, necessitating an immediate shift to a regimen covering necrotizing soft-tissue infections (e.g., vancomycin + piperacillin-tazobactam or a carbapenem + clindamycin). The Pivotal Missed Signals: The foul odor of the pleural fluid was a direct microbiological clue ignored. The subsequent development of severe, disproportionate back pain was the cardinal clinical signal of deep fascial invasion, necessitating an immediate shift to a regimen covering necrotizing soft-tissue infections (e.g., vancomycin + piperacillin-tazobactam or a carbapenem + clindamycin). Delayed Escalation: The switch to moxifloxacin addressed a specific pathogen (Staphylococcus aureus) but neglected the evolving polymicrobial, anaerobic-rich battlefield. The final, appropriate broad-spectrum combination was deployed as a rescue therapy in established septic shock, rather than as an aggressive, pre-emptive strike against a suspected invasive deep tissue infection. Delayed Escalation: The switch to moxifloxacin addressed a specific pathogen (Staphylococcus aureus) but neglected the evolving polymicrobial, anaerobic-rich battlefield. The final, appropriate broad-spectrum combination was deployed as a rescue therapy in established septic shock, rather than as an aggressive, pre-emptive strike against a suspected invasive deep tissue infection. In summary, at each crossroad, the clinical reasoning lagged behind the pathogen’s progression. The diagnostic pause at the onset of disproportionate pain and the therapeutic inertia in broadening antibiotic coverage in the face of clear risk factors and clinical signs were the decisive failures that allowed a localized infection to transform into a systemic and anatomically devastating catastrophe. Limitations This case has several limitations that should be acknowledged. First, the initial diagnostic challenge was significant: the patient developed severe lumbosacral pain three days after thoracic drainage, yet the overlying skin appeared completely normal. This discordance between pain and physical findings—a classic early warning sign of necrotizing fasciitis—was not recognized at the outside hospital, leading to a 10‑day delay in appropriate imaging and surgical consultation. Second, transfer from the outside hospital to our center was delayed until the patient had already developed septic shock and extensive soft-tissue necrosis. Earlier transfer might have enabled timely debridement and improved the chance of survival. Third, anaerobic cultures were not performed on the tissue specimens, and strain-level sequencing of Escherichia coli was unavailable; therefore, we cannot definitively prove clonality between the two sites. Fourth, the lumbar MRI had a limited field of view (L1-S1) and did not visualize the entire fascial tract from the thoracic entry site. Fifth, no autopsy was performed, so the full extent of fascial involvement could not be confirmed post-mortem. These limitations do not diminish the educational value of the case but should be considered when interpreting the findings. Lessons learned This rare yet instructive case underscores several critical lessons that can enhance vigilance and guide management in similar high-risk scenarios: Treat the Vulnerable Host with Heightened Alertness Any invasive procedure in an immunocompromised patient—especially those with cirrhosis, diabetes, or on immunosuppressants—must be regarded as a high-risk event [23]. A lower threshold for broad-spectrum antibiotic coverage and closer postoperative monitoring are warranted. Treat the Vulnerable Host with Heightened Alertness Any invasive procedure in an immunocompromised patient—especially those with cirrhosis, diabetes, or on immunosuppressants—must be regarded as a high-risk event [23]. A lower threshold for broad-spectrum antibiotic coverage and closer postoperative monitoring are warranted. Recognize “Pain Out of Proportion” as a Surgical Emergency Severe, worsening pain that exceeds visible skin changes is a cardinal early sign of necrotizing fasciitis [24]. This symptom should trigger immediate imaging (ultrasound or CT) to evaluate deep fascia and prompt surgical consultation—not merely analgesic administration. Recognize “Pain Out of Proportion” as a Surgical Emergency Severe, worsening pain that exceeds visible skin changes is a cardinal early sign of necrotizing fasciitis [24]. This symptom should trigger immediate imaging (ultrasound or CT) to evaluate deep fascia and prompt surgical consultation—not merely analgesic administration. Understand and Anticipate Anatomic Pathways of Spread Infections can travel along fascial planes far from the original site. In this case, the thoracolumbar fascia and retroperitoneal spaces provided a conduit from chest to lumbosacral region. Awareness of these anatomic continuities should inform imaging review and clinical suspicion when symptoms appear at a distance from a known infection source. Understand and Anticipate Anatomic Pathways of Spread Infections can travel along fascial planes far from the original site. In this case, the thoracolumbar fascia and retroperitoneal spaces provided a conduit from chest to lumbosacral region. Awareness of these anatomic continuities should inform imaging review and clinical suspicion when symptoms appear at a distance from a known infection source. Choose Empiric Antibiotics That Match the Clinical Scenario Foul-smelling pus, post-procedural setting, and immunocompromise should automatically expand empiric coverage to include anaerobes and resistant Gram-positive organisms (e.g., MRSA). Agents such as piperacillin-tazobactam, carbapenems, or combination therapy including vancomycin or metronidazole should be considered early rather than later. Choose Empiric Antibiotics That Match the Clinical Scenario Foul-smelling pus, post-procedural setting, and immunocompromise should automatically expand empiric coverage to include anaerobes and resistant Gram-positive organisms (e.g., MRSA). Agents such as piperacillin-tazobactam, carbapenems, or combination therapy including vancomycin or metronidazole should be considered early rather than later. Implement Early Multidisciplinary Engagement Complex infections bridging body regions (thorax to retroperitoneum) require coordinated input from surgery, infectious diseases, radiology, and critical care teams from the outset. Early discussion can accelerate diagnosis, guide appropriate imaging, and optimize antimicrobial and surgical planning. Implement Early Multidisciplinary Engagement Complex infections bridging body regions (thorax to retroperitoneum) require coordinated input from surgery, infectious diseases, radiology, and critical care teams from the outset. Early discussion can accelerate diagnosis, guide appropriate imaging, and optimize antimicrobial and surgical planning. Monitor with a Dynamic, Low-Threshold Approach Following thoracic drainage or similar procedures, any new or severe pain—especially back, flank, or abdominal pain—should be investigated as potential deep infection until proven otherwise. Daily clinical re-evaluation, including inspection of distant sites, is essential in high-risk patients. Monitor with a Dynamic, Low-Threshold Approach Following thoracic drainage or similar procedures, any new or severe pain—especially back, flank, or abdominal pain—should be investigated as potential deep infection until proven otherwise. Daily clinical re-evaluation, including inspection of distant sites, is essential in high-risk patients. Proposed monitoring algorithm for high‑risk patients after chest drain placement— as presented in Fig. 6. Proposed algorithm for clinical and imaging monitoring after chest drain placement in high-risk patients. This algorithm is intended for immunocompromised patients (e.g., cirrhosis, diabetes, immunosuppressive therapy) who undergo chest drain placement for empyema or parapneumonic effusion, especially when the drained fluid is foul-smelling. Daily clinical assessment focuses on new or disproportionate pain, crepitus, or erythema beyond the drain site. Any positive finding prompts urgent CT of the chest, abdomen, and pelvis. If CT shows fascial gas, fluid, or soft-tissue stranding, immediate surgical consultation is warranted. MRI may be used as a complementary tool when CT findings are equivocal but clinical suspicion persists; the examination should cover the entire potential fascial pathway from the thoracic inlet to the sacrum. This algorithm is derived from a single case and requires prospective validation Based on the lessons from this case, we propose the following practical algorithm for patients with similar risk profiles (immunocompromised, empyema, foul-smelling drainage): Daily clinical assessment: Inspect chest wall, back, and flanks. Specifically query any new or worsening pain, especially if it is disproportionate to physical findings. Daily clinical assessment: Inspect chest wall, back, and flanks. Specifically query any new or worsening pain, especially if it is disproportionate to physical findings. Indications for urgent CT (chest, abdomen, and pelvis): New-onset back/flank pain, fever without an alternative source, palpable crepitus, or erythema/swelling extending beyond the drain site. Indications for urgent CT (chest, abdomen, and pelvis): New-onset back/flank pain, fever without an alternative source, palpable crepitus, or erythema/swelling extending beyond the drain site. Indications for surgical consultation: Presence of fascial gas or fluid on CT, clinical signs of necrotizing fasciitis, or a LRINEC score ≥ 6. Indications for surgical consultation: Presence of fascial gas or fluid on CT, clinical signs of necrotizing fasciitis, or a LRINEC score ≥ 6. Role of MRI: Consider if CT is equivocal and clinical suspicion remains high. Ensure MRI coverage from the thoracic inlet to the sacrum to capture the entire potential fascial pathway. Role of MRI: Consider if CT is equivocal and clinical suspicion remains high. Ensure MRI coverage from the thoracic inlet to the sacrum to capture the entire potential fascial pathway. This algorithm is derived from a single case and requires prospective validation. However, it provides a structured approach to prevent diagnostic and therapeutic delays in similar high-risk scenarios. By integrating these principles into clinical practice, practitioners can improve early detection, initiate timely and appropriate treatment, and potentially prevent the progression of localized infections into fatal systemic catastrophes. Conclusion This report highlights a rare but fatal complication of thoracic drainage, suggesting that in susceptible patients, infection may track subcutaneously and along fascial planes, potentially creating a pathway leading to distant—site NF. Based on this single case, clinicians could consider maintaining a higher index of suspicion for this entity in immunocompromised patients with complex pleural infections. The onset of distant pain that is discordant with local findings might warrant prompt evaluation for deep soft-tissue infection spread, including urgent imaging and surgical consultation. Acknowledgements None. Abbreviations Necrotizing fasciitis computer tomography Laboratory Risk Indicator for Necrotizing Fasciitis Score Acute Physiology and Chronic Health Evaluation II Magnetic Resonance Imaging vacuum-assisted closure methicillin-resistant Staphylococcus aureus Author contributions WL: Conceptualization, Investigation, Data Curation, Writing – Original Draft, Writing – Review & Editing. HS and QL: Investigation, Data Curation, Writing – Review & Editing. JW: Investigation, Visualization, Data Curation, Writing – Review & Editing. MH: Investigation, Writing – Review & Editing, Supervision. QZ: Conceptualization, Project Administration, Investigation, Data Curation, Writing – Review & Editing, Supervision, Corresponding Author. Funding the study was supported by Supported by Fuyang Science and Technology Bureau (No. FK20255506). Data availability All data supporting the findings of this case report are presented in the manuscript. No additional datasets were generated or analyzed. Declarations Ethics approval and consent to participate The need for ethical approval was waived by the Ethics Committee of No.2 People’s Hospital of Fuyang City because this is a retrospective case report. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2024). Written informed consent for publication of clinical details and images was obtained from the patient’s next of kin. Consent for publication Written informed consent was obtained from the patient next of kin for the publication of this case report and any accompanying images. Declaration of AI Use During the preparation of this manuscript, the authors used AI-assisted tools solely for language polishing and formatting. The authors have reviewed and edited the output and take full responsibility for the content of this publication. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement All data supporting the findings of this case report are presented in the manuscript. No additional datasets were generated or analyzed.